Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Peritoneal Neoplasms × Saline Waters × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 10 Cisplatin 10 Hyperthermic Intraperitoneal Chemotherapy 9 Cytoreduction Surgical Procedures 8 Oxaliplatin 7 Mitomycin 5 Fluorouracil 5 Carboplatin 4 Bevacizumab 4 catumaxomab 3 Doxorubicin 3 Docetaxel 3 sodium thiosulfate 2 Leucovorin 2 Drug Therapy 2 Cetuximab 2 volociximab 1 vandetanib 1 relacorilant 1 pasireotide 1 nilotinib 1 farletuzumab 1 enzastaurin 1 birinapant 1 alvimopan 1 Surgical Procedures, Operative 1 Saline Waters 1 Platinum 1 Pemetrexed 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡